Brooks Laboratories Complete Financial Statements
BROOKS • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Brooks Laboratories (BROOKS).
Downloads include all available records across all periods.
For market performance, see the
BROOKS stock price today
.
Profitability Ratios
Net Profit Margin
26.67%
2025 data
EBITDA Margin
30.00%
2025 data
Operating Margin
11.00%
2025 data
Return on Assets
6.45%
2025 data
Return on Equity
8.16%
2025 data
Balance Sheet Ratios
Current Ratio
11.33
2025 data
Debt to Equity
1.27
2025 data
Equity Ratio
79.03%
2025 data
Asset Turnover
0.24
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+42.9%
Year-over-Year
Net Profit Growth
+300.0%
Year-over-Year
EBITDA Growth
+400.0%
Year-over-Year
Expense Growth
-12.5%
Year-over-Year
Assets Growth
+37.8%
Year-over-Year
Equity Growth
+48.5%
Year-over-Year
Liabilities Growth
+37.8%
Year-over-Year
Operating Cash Flow Growth
+130.0%
Year-over-Year
Financing Cash Flow Growth
+320.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Jun 2020 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30 | 24 | 33 | 21 | 18 | 18 | 21 | 24 | 13 | 16 | 22 | 19 | 29 | 17 | 16 | 22 | 15 | 23 | 19 | 30 | 13 | 22 |
| Expenses | 21 | 25 | 22 | 24 | 27 | 20 | 22 | 25 | 16 | 20 | 25 | 27 | 32 | 26 | 24 | 26 | 19 | 22 | 25 | 24 | 13 | 22 |
| EBITDA | 9 | -1 | 10 | -3 | -9 | -2 | -2 | -1 | -4 | -4 | -3 | -9 | -4 | -9 | -8 | -4 | -4 | 1 | -6 | 6 | 0 | 0 |
| Operating Profit Margin % | 11.00% | -5.00% | 12.00% | -16.00% | -54.00% | -11.00% | -7.00% | -5.00% | -29.00% | -25.00% | -15.00% | -51.00% | -14.00% | -50.00% | -56.00% | -20.00% | -31.00% | -2.00% | -34.00% | 18.00% | -2.00% | -3.00% |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 8 | -1 | 10 | -4 | -10 | -2 | -2 | -2 | -4 | -5 | -4 | -12 | -7 | -11 | -11 | -7 | -7 | -2 | -9 | 3 | -3 | -3 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | -1 | -2 | -2 | -2 | 10 | -1 | -1 | 0 | 0 | 0 |
| Net Profit | 8 | -2 | 10 | -4 | -10 | -2 | -2 | -2 | -4 | -5 | -4 | -8 | -6 | -9 | -10 | -5 | -17 | -1 | -7 | 3 | -3 | -3 |
| Earnings Per Share (₹) | 2.71 | -0.54 | 3.25 | -1.51 | -3.77 | -0.94 | -1.75 | -0.60 | -1.75 | -1.81 | -1.51 | -3.19 | -1.46 | -3.80 | -2.03 | -1.97 | -6.93 | -0.47 | -3.14 | 1.35 | 0.00 | -1.03 |
Related Pages for Brooks Laboratories
Additional stock information and data for BROOKS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 124 | 90 | 110 | 196 | 162 |
| Current Assets | 34 | 31 | 28 | 61 | 47 |
| Fixed Assets | 14 | 14 | 15 | 110 | 108 |
| Capital Work in Progress | 0 | 0 | 0 | 15 | 1 |
| Investments | 74 | 43 | 64 | 0 | 0 |
| Other Assets | 36 | 34 | 31 | 71 | 54 |
| LIABILITIES | |||||
| Total Liabilities | 124 | 90 | 110 | 196 | 162 |
| Current Liabilities | 3 | 2 | 3 | 13 | 19 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 98 | 66 | 74 | 134 | 79 |
| Share Capital | 30 | 26 | 25 | 25 | 25 |
| Reserves & Surplus | 69 | 39 | 49 | 63 | 54 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 3 | -10 | -15 | -37 | 5 |
| Investing Activities | -45 | 0 | 1 | -25 | -5 |
| Financing Activities | 42 | 10 | 11 | 64 | 1 |
| Net Cash Flow | 0 | 0 | -3 | 2 | 1 |